Precigen (PGEN) Intangibles (2012 - 2026)
Precigen (PGEN) reported Intangibles of $2.9 million for Q1 2026, down 30.75% year-over-year from $4.1 million in Q1 2025, and down 9.99% quarter-over-quarter from $3.2 million in Q4 2025.
Precigen (PGEN) Intangibles (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Intangibles data on file, last reported at $2.9 million in Q1 2026.
- Intangibles for Q1 2026 came in at $2.9 million, down 30.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.9 million (down 30.75% YoY), and the FY2025 annual result was $3.2 million, down 28.57% from the prior year.
- Intangibles declined to $2.9 million in Q1 2026 per PGEN's latest filing, from $3.2 million in the prior quarter.
- Over five years, Intangibles peaked at $51.4 million in Q1 2022 and troughed at $2.9 million in Q1 2026.
- A 5-year average of $24.8 million and a median of $38.7 million in 2024 frame the typical range for Intangibles.
- The sharpest annual moves came in 2023 and 2025: Intangibles dropped 4.69% in 2023, then tumbled 89.32% in 2025.
- A 5-year view of Intangibles shows it stood at $44.5 million in 2022, then dropped by 8.44% to $40.7 million in 2023, then plunged by 89.05% to $4.5 million in 2024, then declined by 28.57% to $3.2 million in 2025, then decreased by 9.99% to $2.9 million in 2026.
- Business Quant data shows PGEN's Intangibles at $2.9 million in Q1 2026, $3.2 million in Q4 2025, and $3.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 7.73 Mn |
| 10 | Precigen | 1.32 Bn | 1.32 Bn | 20.69 Mn | 2.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.86 Mn |
| Dec 31, 2025 | 3.18 Mn |
| Sep 30, 2025 | 3.50 Mn |
| Jun 30, 2025 | 3.82 Mn |
| Mar 31, 2025 | 4.14 Mn |
| Dec 31, 2024 | 4.46 Mn |
| Sep 30, 2024 | 4.77 Mn |
| Jun 30, 2024 | 5.09 Mn |
| Mar 31, 2024 | 38.72 Mn |
| Dec 31, 2023 | 40.70 Mn |
| Sep 30, 2023 | 40.43 Mn |
| Jun 30, 2023 | 42.66 Mn |
| Mar 31, 2023 | 43.85 Mn |
| Dec 31, 2022 | 44.46 Mn |
| Sep 30, 2022 | 42.42 Mn |
| Jun 30, 2022 | 45.93 Mn |
| Mar 31, 2022 | 51.43 Mn |
| Dec 31, 2021 | 52.29 Mn |
| Sep 30, 2021 | 56.91 Mn |
| Jun 30, 2021 | 59.94 Mn |